55 results on '"Nazir, J."'
Search Results
2. PSY7 Cost-Minimisation Analysis of Recombinant Factor VIII FC Fusion Protein Versus Emicizumab for Haemophilia a Prophylaxis in Europe.
3. PRO116 Interactive Online Survey on Treatment Patterns and Patient Preferences Towards Thrombopoietin Receptor-Agonists in Immune Thrombocytopenia (TRAPEZE).
4. ANTIBODY RESPONSE OF GOATS TO GEL BASED COMBINED VACCINE AGAINST PESTE DES PETITS RUMINANTS, CONTAGIOUS CAPRINE PLEUROPNEUMONIA AND FOOT AND MOUTH DISEASE.
5. PUK11 - Estimating The Economic and Clinical Benefits of Mirabegron Versus Antimuscarinics for The Treatment of Overactive Bladder (OAB) in The United Kingdom (UK).
6. Cost-Consequences Analysis Of Treatment Regimens Used For The Management Of Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph).
7. Cost-Effectiveness Of A Fixed-Dose Combination Of Solifenacin And Tamsulosin In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph).
8. An incidence model of the cost of advanced prostate cancer in Spain.
9. PUK21 Cost-Effectiveness Analysis of Solifenacin Succinate Versus Trospium Chloride in the Treatment of Patients with Overactive Bladder in Germany
10. ISOLATION, CHARACTERIZATION AND EFFECT OF AUXIN PRODUCING BACTERIA ON GROWTH OF TRITICUM AESTIVUM.
11. PRO35 Characterization and Treatment of Immune Thrombocytopenia (ITP) in Europe: A Qualitative Observational Study.
12. Seroprevalence of Bluetongue Virus in small ruminants in Balochistan province, Pakistan.
13. Role of water chemistry and stabilizers on the Vero-cells-based infectivity of Newcastle disease virus live vaccine.
14. EFFECT OF COLCHICINE ON CELLULAR IMMUNE RESPONSES IN MICE.
15. EFFECT OF COLCHICINE ON HUMORAL IMMUNITY AND IMMUNE ORGANS IN MICE.
16. PREVALENCE OF GROUP A BOVINE ROTA VIRUS IN NEONATAL CALVES IN PUNJAB, PAKISTAN.
17. PCR284 Fatigue and Health-Related Quality of Life in Paroxysmal Nocturnal Haemoglobinuria (PNH): A Post-Hoc Analysis of Pegcetacoplan Pegasus Facit-Fatigue Trial Data.
18. PUK20 - Assessing Change In Health-Related Quality Of Life With Mirabegron Add-On Therapy To Solifenacin In Incontinent Patients With Overactive Bladder: An Analysis Of Eq 5d-5l And Oab-5d Data From The Beside Clinical Trial.
19. PUK16 - Conceptual Framework In Interstitial Cystitis / Bladder Pain Syndrome.
20. PUK4 - The Budget Impact of Treatment Pathway Redesign In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph).
21. Cost-Effectiveness Of Mirabegron 50mg Compared To Tolterodine Er 4mg In The Treatment Of Patients With Overactive Bladder In Canada.
22. ISOLATION AND CHARACTERIZATION OF PHYTASE PRODUCING BACTERIAL ISOLATES FROM SOIL.
23. HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDIES FOR THE PATHOGENESIS OF A LOW PATHOGENICITY H9 AVIAN INFLUENZA VIRUS IN EXPERIMENTALLY INFECTED COMMERCIAL BROILERS.
24. COMPARATIVE DIAGNOSTIC APPLICATIONS OF ANTIGEN CAPTURE ELISA AND IMMUNOHISTOCHEMISTRY FOR DETECTION OF BOVINE VIRAL DIARRHEA PERSISTENT INFECTION.
25. Economic Evaluation of Pharmacological Treatments for Overactive Bladder.
26. REPEATABILITY OF ANTRAL FOLLICULAR COUNT AND ITS CORRELATION WITH SUPER STIMULATION IN NILI-RAVI BUFFALOES.
27. IN PROCESS QUALITY CONTROL FACTORS EFFECTING POTENCY OF PESTE DES PETITS RUMINANTS VIRUS VACCINES IN GOATS.
28. PRO50 The Economic Burden of Congenital Haemophilia without Inhibitors By Disease Severity: A Regression Analysis of Paediatric and Adult Patients in the "Cost of Haemophilia in Europe: A Socioeconomic Survey".
29. POSB353 Quality of Life and Symptom Burden of Paroxysmal Nocturnal Hemoglobinuria Among Patients Receiving C5 Inhibitors in the United States and Europe.
30. Comparative efficacy and safety of treatments for the management of overactive bladder: A systematic literature review and mixed treatment comparison.
31. PUK5 a Systematic Review and Meta-Analysis of Solifenacin Succinate Versus Trospium Chloride for Overactive Bladder
32. PDB34 Comparative Efficacy and Safety of Avatrombopag Versus Lusutrombopag in Patients with Chronic LIVER Disease and Severe Thrombocytopenia Undergoing Invasive Procedures: A Systematic Literature Review and Network Meta-Analysis.
33. Antibacterial effects of laser ablated Ni nanoparticles.
34. PSY1 Matching-Adjusted Indirect Comparison of the Efficacy of Recombinant Factor VIII FC and Bay 94-9027 for the Treatment of Patients with Haemophilia a.
35. PSY2 Efficacy Of rFVIIIFc Versus Emicizumab For The Treatment of Patients With Haemophilia A Without Inhibitors: Matching-Adjusted Indirect Comparison Of A-LONG And HAVEN Trials.
36. PIH4 An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (SJIA).
37. 1096 - Quality of life in older patients with overactive bladder treated with mirabegron in routine clinical practice: Secondary analysis of a pan-European non-interventional study (BELIEVE).
38. PUK10 - Estimating The Economic Benefit Of Treatment With Alpha-Blocker Plus Antimuscarinic As A Fixed-Dose Combination (FDC) Tablet Versus Concomitant Combination Therapy (CCT) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (BPH)
39. Economic Evaluation Of Mirabegron Versus Antimuscarinic Treatments In Patients With Overactive Bladder From The Pespective Of The Spanish National Health Service.
40. Cost-Effectiveness Of A Fixed-Dose Combination Of Solifenacin Plus Tamsulosin Ocas For The Treatment Of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia In Spain.
41. PIN33 - A Cost-effectiveness and Budget Impact Analysis of Fidaxomicin for Treating Clostridium Difficile Patients In Germany.
42. Men's Preferences For The Treatment Of Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph): A Discrete Choice Experiment (Dce).
43. Comparative Efficacy And Tolerability Of Solifenacin 5mg Versus Oral Antimuscarinic Agents In Overactive Bladder (Oab): A Systematic Literature Review (Slr) And Mixed Treatment Comparison (Mtc).
44. Cost Effectiveness Of Solifenacin Compared With Oral Antimuscarinic Agents For The Treatment Of Patients With Overactive Bladder (Oab) In The Uk.
45. A Mixed Methods Approach (Mma) To Understanding Men's Attitudes Toward The Management Of Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph).
46. Using Eq-5d-3l And Oab-5d To Assess Changes In Health-Related Quality Of Life (Hrqol) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph).
47. Economic Evaluation Of Fidaxomicin Compared With Vancomycin In The Treatment Of Clostridium Difficile Infection.
48. Elicitation of Health-Related Quality of Life Concepts Associated with Overactive Bladder.
49. Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom.
50. Cost-Effectiveness of Mirabegron Compared with Tolterodine ER 4mg for the Treatment of Patients with Overactive Bladder in the United Kingdom: Results from a Trial-Based Model.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.